KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 295 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $7,058,173 | +3110.9% | 22,300 | +1615.4% | 0.01% | – |
| Q3 2023 | $219,817 | -22.0% | 1,300 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $281,905 | +19.4% | 1,300 | 0.0% | 0.00% | – |
| Q1 2023 | $236,132 | -82.6% | 1,300 | -87.9% | 0.00% | -100.0% |
| Q2 2022 | $1,357,000 | -43.5% | 10,730 | -43.3% | 0.00% | -50.0% |
| Q1 2022 | $2,400,000 | -4.8% | 18,930 | -1.8% | 0.00% | 0.0% |
| Q4 2021 | $2,521,000 | +7.0% | 19,269 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,357,000 | +7.5% | 19,269 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $2,193,000 | -13.5% | 19,242 | -8.7% | 0.00% | 0.0% |
| Q1 2021 | $2,535,000 | -13.4% | 21,086 | -26.8% | 0.00% | -33.3% |
| Q4 2020 | $2,928,000 | +18.4% | 28,816 | -9.9% | 0.00% | 0.0% |
| Q3 2020 | $2,472,000 | -39.2% | 31,972 | -12.3% | 0.00% | -40.0% |
| Q2 2020 | $4,064,000 | +123.4% | 36,463 | +44.4% | 0.01% | +150.0% |
| Q1 2020 | $1,819,000 | – | 25,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |